Effect of Phosphodiesterase-5 Inhibition With Tadalafil on SystEmic Right VEntricular Size and Function

Clinical trial NCT03049540 · COMPLETED

Trial details

NCT number: NCT03049540
Sponsor: Insel Gruppe AG, University Hospital Bern
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Heart Defects, Congenital Transposition of Great Vessels With Ventricular Inversion

Start date: 2017-10-25
Primary completion: 2021-10-28
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.